Data / Form D filings / Braxia Scientific Corp.
Braxia Scientific Corp.: Form D filings
Braxia Scientific Corp., a health care company in Vancouver, British Columbia, Canada, filed 6 Form D notices with the SEC between 2020 and 2024. The latest, on March 21, 2024, reports $249,024 sold of a $730,060 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2300 - 1177 WEST HASTINGS STREET, Vancouver, British Columbia, Canada, V6E2K
- Phone
- (604) 525-9409
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2019
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815476
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | Amendment | $730,060 | $249,024 | $481,036 | 3 | Feb 27, 2023 | sec.gov |
| Aug 23, 2023 | Amendment | $2,283,537 | $2,283,537 | 35 | Aug 2, 2022 | sec.gov | |
| Mar 24, 2023 | New notice | $730,060 | $249,024 | $481,036 | 3 | Feb 27, 2023 | sec.gov |
| Aug 22, 2022 | New notice | $2,283,537 | $2,283,537 | 35 | Aug 2, 2022 | sec.gov | |
| Feb 14, 2022 | New notice | $5,323,763 | $2,366,078 | $2,957,685 | 4 | Jan 10, 2022 | sec.gov |
| Jun 23, 2020 | New notice | $1,593,573 | $950,552 | $643,021 | 2 | Jun 11, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Kratiuk | Executive Officer | |
| Peter Rizakos | Executive Officer | |
| Jerry Habuda | Director | |
| Stephen Brooks | Executive Officer | |
| Daniel Herrera | Executive Officer | |
| Jason Wolkove | Executive Officer | |
| Roger McIntyre | Executive Officer, Director | |
| Joshua Rosenblat | Executive Officer | |
| Olga Cwiek | Director |
Every Form D from the week of Mar 18, 2024 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Braxia Scientific Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.